Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study

• Gianfranco Spalletta ,

  * E-mail: g.spalletta@hsantalucia.it

  Affiliation Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy

  ⨯
• Carlo Caltagirone,

  Affiliations Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy, Department of System Medicine, University of Rome “Tor Vergata”, Rome, Italy

  ⨯
• Alessandro Padovani,

  Affiliation Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

  ⨯
• Sandro Sorbi,

  Affiliation Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy

  ⨯
• Mahmood Attar,

  Affiliation Novartis Farma Italia, Origgio (Varese), Italy

  ⨯
• Delia Colombo,

  Affiliation Novartis Farma Italia, Origgio (Varese), Italy

  ⨯
• Luca Cravello,

  Affiliation Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy

  ⨯
• on behalf of the E V O L U T I O N study Working Group

  ¶Membership of the EVOLUTION study Working Group is provided in the Acknowledgments.

  ⨯